Skip to main navigation
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Contact
  • Pipeline
    • Overview
    • Herpesviruses
    • Viral Hepatitis
    • Research & Discovery
    • Publications
  • Patients
    • Commitment
    • Resources
    • Clinical Studies
  • Sustainability
    • Overview
    • Business Ethics
    • Access to Health Care
    • Human Capital
    • Environment, Health & Safety
  • Collaborations
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
  • Careers
    • Culture
    • Benefits
    • Opportunities
On the
  • Press Releases
  • Events & Presentations

Event Details

American Association for the Study of Liver Diseases (AASLD) – The Liver Meeting 2025

Nov 7 - Nov 11, 2025

Supporting Materials

ABI-4334 - Safety, PK, and Antiviral Activity of the Next-Generation Hepatitis B CAM ABI-4334 in Patients With HBeAg-Negative Chronic Hepatitis B Infection Not Suppressed on Nucleoside Analogues: Results From a Randomized, Blinded, Phase 1b Study 215.3 KB
Shareholder Tools Print Email Alerts RSS News Feeds
Search Investors

Contact Us

Contact Us

833.509.4583 info@assemblybio.com LinkedIn
AssemblyBio logo
 
Privacy Notice Cookie Policy

© 2026 Assembly Biosciences, Inc.